» Articles » PMID: 8042602

Treatment Process and Relapse to Opioid Use During Methadone Maintenance

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 1994 Jan 1
PMID 8042602
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

A general framework for studying drug abuse treatment process factors is presented, and components are then used to predict relapse to opioid use during treatment in methadone maintenance. Major domains of the treatment process research framework include client variables at entry, program characteristics, treatment events, and client outcomes. The analyses rely on the use of proportional hazards models to identify significant outcome predictors in a sample of 590 methadone maintenance clients from 21 clinics in the Research Triangle Institute/Treatment Outcome Prospective Study (RTI/TOPS) data system who remained in treatment at least 3 months. The analyses were performed on the total sample and separately on clients from three groups of clinics classified on the basis of the distribution of client relapse rates and tenure in treatment. Relapse rates were related to dosage level, client monitoring with urinalyses, and methadone take-home privileges in some clinics, and hence, these time-varying treatment events were important factors in treatment outcomes. Even at entry to treatment, some measures were found to be related to how the client later performed during treatment. Finally, it was also found that the particular area of professional speciality of the staff making client diagnosis at intake and preparing treatment plans was associated with client outcomes.

Citing Articles

Environmental enrichment facilitates electric barrier induced heroin abstinence after incubation of craving in male and female rats.

Barrera E, Timken P, Lee E, Persaud K, Goldstein H, Parasram D Drug Alcohol Depend. 2023; 244:109799.

PMID: 36774806 PMC: 9982754. DOI: 10.1016/j.drugalcdep.2023.109799.


Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.

Chawar C, Hillmer A, Lamri A, Kapczinski F, Thabane L, Pare G PLoS One. 2021; 16(12):e0261201.

PMID: 34910759 PMC: 8673616. DOI: 10.1371/journal.pone.0261201.


Environmental enrichment reduces heroin seeking following incubation of craving in both male and female rats.

Barrera E, Loughlin L, Greenberger S, Ewing S, Hachimine P, Ranaldi R Drug Alcohol Depend. 2021; 226:108852.

PMID: 34225225 PMC: 8355213. DOI: 10.1016/j.drugalcdep.2021.108852.


GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol.

Chawar C, Hillmer A, Sanger S, DElia A, Panesar B, Guan L Syst Rev. 2020; 9(1):200.

PMID: 32873330 PMC: 7466496. DOI: 10.1186/s13643-020-01461-z.


The Influence of Client Risks and Treatment Engagement on Recidivism.

Yang Y, Knight K, Joe G, Rowan-Szal G, Lehman W, Flynn P J Offender Rehabil. 2018; 52(8):544-564.

PMID: 29353986 PMC: 5773110. DOI: 10.1080/10509674.2013.840353.